Evotec SE (EVOTF)
PNK: EVOTF
· Real-Time Price · USD
8.27
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 7.96 |
| Market Cap | 1.47B |
| Revenue (ttm) | 796.97M |
| Net Income (ttm) | -196.08M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -7.52 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 8.84 |
| Volume | 100 |
| Avg. Volume (20D) | 171.916 |
| Open | 9.22 |
| Previous Close | 8.27 |
| Day's Range | 8.27 - 9.22 |
| 52-Week Range | 6.57 - 10.18 |
| Beta | 1.09 |
About EVOTF
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly;...
Sector Healthcare
IPO Date Oct 7, 2009
Employees 4,740
Stock Exchange PNK
Ticker Symbol EVOTF
Website https://www.evotec.com